Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Methyl 2-Cyano-3,11-dioxo-18β-olean-1,12-dien-30-oate Is a Peroxisome Proliferator-Activated Receptor-γ Agonist That Induces Receptor-Independent Apoptosis in LNCaP Prostate Cancer Cells

Sabitha Papineni, Sudhakar Chintharlapalli and Stephen Safe
Molecular Pharmacology February 2008, 73 (2) 553-565; DOI: https://doi.org/10.1124/mol.107.041285
Sabitha Papineni
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sudhakar Chintharlapalli
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen Safe
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 73 no. 2 553-565
DOI 
https://doi.org/10.1124/mol.107.041285
PubMed 
17989348

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received August 28, 2007
  • Accepted November 7, 2007
  • Published online January 23, 2008.

Article Versions

  • Earlier version (November 7, 2007 - 12:53).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Sabitha Papineni,
  2. Sudhakar Chintharlapalli and
  3. Stephen Safe
  1. Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, Texas (S.P., S.S.); and Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, Texas (S.C., S.S.)
  1. Address correspondence to:
    Dr. Stephen Safe, Department of Veterinary Physiology and Pharmacology, Texas A&M University, 4466 TAMU, College Station, TX 77843-4466. E-mail: ssafe{at}cvm.tamu.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: November 2007 to January 2023

AbstractFullPdf
Nov 2007220111
Dec 20078053
Jan 200839960
Feb 2008371924
Mar 2008361816
Apr 2008391410
May 2008261912
Jun 200832147
Jul 200844116
Aug 2008601114
Sep 20084167
Oct 200834143
Nov 200826139
Dec 20082146
Jan 20093056
Feb 2009212221
Mar 2009391819
Apr 2009241016
May 2009141211
Jun 2009141919
Jul 200914217
Aug 2009141616
Sep 2009181710
Oct 2009212017
Nov 200933912
Dec 20093566
Jan 2010461112
Feb 201036612
Mar 201028510
Apr 201025107
May 201044156
Jun 201022106
Jul 20103989
Aug 201055116
Sep 20101879
Oct 2010121212
Nov 201012139
Dec 201092313
Jan 2011141212
Feb 201114158
Mar 201113146
Apr 2011161213
May 201161115
Jun 201161114
Jul 2011241015
Aug 2011171518
Sep 2011201920
Oct 2011231712
Nov 2011262315
Dec 2011291214
Jan 2012201512
Feb 20122377
Mar 2012321611
Apr 2012191012
May 2012261215
Jun 20122397
Jul 2012501114
Aug 2012141210
Sep 20121497
Oct 2012171311
Nov 2012221313
Dec 201215108
Jan 2013322211
Feb 2013261711
Mar 201328610
Apr 2013201514
May 20132899
Jun 201312811
Jul 2013723
Aug 20131457
Sep 20131076
Oct 201323627
Nov 20131661
Dec 20131230
Jan 201417107
Feb 20141845
Mar 20141054
Apr 20142145
May 201413134
Jun 20141621
Jul 20141374
Aug 20141023
Sep 2014668
Oct 201410162
Nov 2014131815
Dec 20141256
Jan 20151522
Feb 2015911
Mar 20152695
Apr 20152641
May 201521167
Jun 20151281
Jul 2015301810
Aug 201524112
Sep 20151262
Oct 20151565
Nov 2015922
Dec 20151855
Jan 20162235
Feb 20161184
Mar 20161837
Apr 20161723
May 2016966
Jun 20161558
Jul 2016833
Aug 20161362
Sep 20161190
Oct 20168156
Nov 201613133
Dec 201681412
Jan 20170135
Feb 20170123
Mar 201702211
Apr 20170174
May 201711915
Jun 20170125
Jul 20170122
Aug 20172184
Sep 20173106
Oct 20170145
Nov 201711713
Dec 20173235
Jan 20184136
Feb 20180114
Mar 20184167
Apr 20181164
May 2018380
Jun 20181188
Jul 20180426
Aug 2018080
Sep 20180482
Oct 20180136
Nov 2018071
Dec 20182042
Jan 20191725
Feb 2019502
Mar 20192004
Apr 2019904
May 2019502
Jun 2019806
Jul 2019532
Aug 20191401
Sep 2019913
Oct 20192522
Nov 20191823
Dec 20192511
Jan 2020601
Feb 20201000
Mar 2020800
Apr 2020701
May 2020411
Jun 20202600
Jul 2020812
Aug 2020601
Sep 2020400
Oct 2020801
Nov 2020802
Dec 20201232
Jan 2021931
Feb 2021931
Mar 20211110
Apr 2021710
May 20212521
Jun 2021530
Jul 20211113
Aug 2021620
Sep 20211010
Oct 20211400
Nov 20211020
Dec 2021722
Jan 20221363
Feb 2022720
Mar 2022310
Apr 20221412
May 20221200
Jun 20221010
Jul 2022522
Aug 2022611
Sep 2022410
Oct 20221133
Nov 2022810
Dec 2022410
Jan 2023731

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 73 (2)
Molecular Pharmacology
Vol. 73, Issue 2
1 Feb 2008
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Methyl 2-Cyano-3,11-dioxo-18β-olean-1,12-dien-30-oate Is a Peroxisome Proliferator-Activated Receptor-γ Agonist That Induces Receptor-Independent Apoptosis in LNCaP Prostate Cancer Cells
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Methyl 2-Cyano-3,11-dioxo-18β-olean-1,12-dien-30-oate Is a Peroxisome Proliferator-Activated Receptor-γ Agonist That Induces Receptor-Independent Apoptosis in LNCaP Prostate Cancer Cells

Sabitha Papineni, Sudhakar Chintharlapalli and Stephen Safe
Molecular Pharmacology February 1, 2008, 73 (2) 553-565; DOI: https://doi.org/10.1124/mol.107.041285

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Methyl 2-Cyano-3,11-dioxo-18β-olean-1,12-dien-30-oate Is a Peroxisome Proliferator-Activated Receptor-γ Agonist That Induces Receptor-Independent Apoptosis in LNCaP Prostate Cancer Cells

Sabitha Papineni, Sudhakar Chintharlapalli and Stephen Safe
Molecular Pharmacology February 1, 2008, 73 (2) 553-565; DOI: https://doi.org/10.1124/mol.107.041285
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • The binding site for KCI807 in the androgen receptor
  • Fatty acid amide hydrolase in cisplatin nephrotoxicity
  • eCB Signaling System in hiPSC-Derived Neuronal Cultures
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics